Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival.
By Thomas J. Smith, P. Staats, T. Deer, L. Stearns, R. Rauck, R. Boortz-Marx, E. Buchser, E. Catalá, D. Bryce, P. Coyne and 1 more. Journal of Clinical Oncology, 2002
630 citations recorded by the source corpus.
Subfields: Anesthesiology and Pain Medicine, Pulmonary and Respiratory Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/9ea8e7b61bfe6d91dd7f2015ab920116557bb3f6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- elliot k fishman
- A. Klein
- J. Herman
- D. Laheru
- R. Hruban
- E. Fishman
- M. Erdek
Citations in the corpus
- Recent progress in pancreatic cancer (2013, background): “Randomized, controlled studies have delineated the benefit of this therapeutic modality, not only for pain control, but particularly in minimizing the toxicities of systemically administered opioids.(222) Ongoing consultation with a pain specialist is advised to optimize an integrated approach to ph”